Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts

Blood, Vol. 112, Issue 13, 4971-4980, December 15, 2008
This Article
Right arrow Abstract
Right arrow Full Text
Services
Right arrow Email this article to a friend
Right arrow Alert me to new issues of the journal
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef

Stimulation of dendritic cells via the dectin-1/Syk pathway allows priming of cytotoxic T-cell responses
Blood LeibundGut-Landmann et al. 112: 4971

Supplemental materials for: LeibundGut-Landmann et al

Files in this Data Supplement:

  • Figure S1. Plasmacytoid DC respond poorly to curdlan (JPG, 68.8 KB) -
    (A) Bone marrow cells that were grown in vitro in the presence of Flt3L were stimulated with curdlan (50 µg/ml) or CpG (0.5 µg/ml) for 18 hours. Brefeldin A was added for the last 5 hours. IL-12 p40 staining of the pDC (CD11c+CD11bB220+) and conventional DC populations (CD11c+CD11bB220+) is shown. Numbers represent percentage of events in the indicated gate. (B) Expression of Dectin-1 on pDC and conventional DC generated in vitro in the presence of Flt3L. Cells were stained with anti–Dectin-1 (thick line) or rat IgG2b (solid grey). DC subtypes were defined by gating on CD11c+CD11bB220+ (pDC) and CD11c+CD11bB220+ cells (conventional DC) respectively. Numbers indicate mean fluorescence intensity (GeoMFI).





  • Figure S2. The adjuvant effect of curdlan is MyD88-independent (JPG, 53.2 KB) -
    MyD88-deficient and C57Bl/6 control mice were immunized in both hind footpads with OVA protein alone (none) or together with curdlan as indicated. Target cells were injected six days later and mice were analyzed on day 7. (A) The frequency of SIINFEKL-H2Kb tetramer+ CD8+ splenocytes is shown. Each dot represents an individual mouse from two pooled experiments. (B) In vivo CTL activity measured by target cell elimination. Individual mice from 2 pooled experiments are shown. Differences between C57BL/6 and myd88−∕− groups in both (A) and (B) were not statistically different (p>0.05).





  • Figure S3. IL-12 p70 is not essential for CTL priming in vivo (JPG, 52.3 KB) -
    IL-12 p35-deficient and C57Bl/6 control mice were immunized in both hind footpads with OVA protein alone (none) or together with curdlan as indicated. Target cells were injected six days later and mice were analyzed on day 7. (A) The frequency of SIINFEKL-H2Kb tetramer+ CD8+ splenocytes is shown. Each dot represents an individual mouse from two pooled experiments. (B) In vivo CTL activity measured by target cell elimination. Individual mice from 2 pooled experiments are shown. Differences between C57BL/6 and p35−∕− groups in both (A) and (B) were not statistically different (p>0.05).





This Article
Right arrow Abstract
Right arrow Full Text
Services
Right arrow Email this article to a friend
Right arrow Alert me to new issues of the journal
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef

 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2009 by American Society of Hematology         Online ISSN: 1528-0020